Britain's pharmacy regulator warned it had been forced to step in, to 'investigate concerns' that prescription drugs had been ...

A weight loss pill called orforglipron has had some successful results from the human trial stage, so when could we see it on the NHS?

A trial of 3,127 patients who took a daily pill for 72 weeks saw an average weight loss per person of 12.3kg. While injectable obesity drugs are peptides designed to replicate the appetite-controlling ...

A new daily weight loss pill could be available soon – and a recent trial has shown that people taking the drug can shed ...

Lisa Bernett lost more than 10 stone without jabs or surgery. She shares how she transformed her eating habits and fitness ...

KATIE Price has revealed how much weight her son Harvey has lost just a week after he moved to a new home. Former glamour ...

Doctors from only four medical specialties will be able to write prescriptions for injectable drugs that are used to treat ...

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...

A late-stage study tested three doses of Eli Lilly’s oral GLP-1 drug, Orforglipron, in more than 3,100 adults, with the ...

Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight ...

Eli Lilly stock beats Q2 estimates with strong sales but faces competitive risks and high valuation. Here's why investors may ...